IDEXX Laboratories (MIL:1IDXX) Beta: N/A (As of Jun. 29, 2026)


MIL:1IDXX IDEXX Laboratories Inc MIL:1IDXX
29 GF Score
Price €488.50
GF Value €558.80
Valuation Modestly Undervalued
View Full Analysis

What is IDEXX Laboratories Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-29), IDEXX Laboratories's Beta is Not available.

IDEXX Laboratories  (MIL:1IDXX) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

IDEXX Laboratories Beta Related Terms

IDEXX Laboratories Beta Historical Data

* Premium members only.

The historical data trend for IDEXX Laboratories's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories Beta Chart

IDEXX Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IDEXX Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MIL:1IDXX
29GF Score
IDEXX Laboratories Inc MIL:1IDXX
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEXX Laboratories Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is IDEXX Laboratories (MIL:1IDXX) Overvalued in 2026?

Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued. The current stock price of €488.50 is trading 12.6% below its estimated GF Value™ of €558.80. GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.

Key valuation signals for MIL:1IDXX:

  • Beta: N/A
  • GF Value™: €558.80 vs. price of €488.50 (12.6% below fair value)
  • GF Score™: 29/100

No single metric tells the full story. See the MIL:1IDXX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEXX Laboratories Business Description

Address One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
29GF Score

Get the complete analysis for MIL:1IDXX

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€488.50
Price
€558.80
GF Value